BIOSOM PHARMA is an innovative pharmaceutical company from Austria, specializing in the development and production of highly effective medications and biotechnological solutions. The company’s mission is to improve the quality of life worldwide through scientific research, innovation, and strict quality standards.
Company History
BIOSOM PHARMA was founded in 2005 by a group of Austrian scientists and entrepreneurs inspired by the idea of combining advanced biotechnology and pharmaceuticals to create safe and effective medications. Initially, the company started as a small laboratory in Vienna focused on researching rare diseases.
In 2010, BIOSOM PHARMA launched its first commercially successful product—an innovative medication for the treatment of chronic inflammatory diseases, which gained recognition not only in Austria but also in international markets. This marked a turning point, establishing the company’s reputation as a reliable developer of innovative pharmaceuticals.
Since 2015, the company has actively invested in biotechnological research, including gene therapies and immunological drugs. With modern laboratories and international partnerships, BIOSOM PHARMA has expanded its presence across Europe, Asia, and North America.
Today, BIOSOM PHARMA is a team of over 500 highly qualified specialists working in pharmacology, bioengineering, and clinical research. The company prides itself on its approach, which combines scientific rigor, ethical standards, and innovative thinking aimed at improving people’s health worldwide.
After successfully strengthening its position in the pharmaceutical market for treating chronic and rare diseases, BIOSOM PHARMA began expanding its scientific horizons into metabolic and hormonal therapy. The company’s attention turned to compounds capable of effectively supporting muscle growth, accelerating tissue recovery, and improving overall physical endurance in patients with osteoporosis, sarcopenia, and other conditions associated with muscle loss.
Since 2018, BIOSOM PHARMA has invested in its own research on the synthesis and biochemical optimization of steroid compounds, aiming to create drugs with high efficacy and minimal risk of side effects. Leveraging its extensive experience in pharmaceuticals and biotechnology, the company developed innovative anabolic steroid formulations designed for both medical use and scientific research in sports medicine.
Today, BIOSOM PHARMA’s anabolic steroid division combines strict GMP (Good Manufacturing Practice) standards with clinical research, ensuring a high level of safety and product quality. This strategic move has allowed the company not only to expand its product range but also to strengthen its position as a leader in the biopharmaceutical sector for restoring and maintaining muscle function.
